Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.
about
Debate: Should the elderly receive thrombolytic therapy or primary angioplasty?Debate: Should the elderly receive thrombolytic therapy, or primary angioplasty, for acute myocardial infarction? The case for primary angioplastyShort-Term Effects of Verapamil and Diltiazem in the Treatment of No Reflow Phenomenon: A Meta-Analysis of Randomized Controlled TrialsThe coronary slow flow phenomenon: characteristics, mechanisms and implicationsRisks and Benefits of Thrombolytic, Antiplatelet, and Anticoagulant Therapies for ST Segment Elevation Myocardial Infarction: Systematic ReviewRevascularization grading in endovascular acute ischemic stroke therapyCoronary artery disease in women: a review on prevention, pathophysiology, diagnosis, and treatmentPharmacodynamics and safety of lefradafiban, an oral platelet glycoprotein IIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplastyOutcomes of ≤6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation: A meta-analysis and meta-regression.Defining optimal activated clotting time for percutaneous coronary intervention: A systematic review and Bayesian meta-regression.Efficacy and Safety of High-Dose Subcutaneous Unfractionated Heparin Prophylaxis for the Prevention of Venous Thromboembolism in Obese Hospitalized Patients.Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement.Risk of renal dysfunction after less invasive multivessel coronary artery bypass grafting.High incidence of acute coronary occlusion in patients without protocol positive ST segment elevation referred to an open access primary angioplasty programme.Enhancement of fibrinolysis in vitro by ultrasound.Coronary flow velocity analysis during short term follow up after coronary reperfusion: use of transthoracic Doppler echocardiography to predict regional wall motion recovery in patients with acute myocardial infarction.Periprocedural aspects in mechanical recanalization for acute stroke: data from the ENDOSTROKE registry.Laser thrombolysis in acute myocardial infarction: results of a clinical feasibility study.Effects of clopidogrel on mortality, cardiovascular and bleeding outcomes in patients with chronic kidney disease - data from Taiwan acute coronary syndrome full spectrum registry.Additive effect of in-hospital TIMI bleeding and chronic kidney disease on 1-year cardiovascular events in patients with acute coronary syndrome: Data from Taiwan Acute Coronary Syndrome Full Spectrum Registry.Editor's Choice- Gender difference in prognostic impact of in-hospital bleeding after myocardial infarction - data from the SWEDEHEART registry.Prevention of distal embolization and no-reflow in patients with acute myocardial infarction and total occlusion in the infarct-related vessel: a subgroup analysis of the cohort of acute revascularization in myocardial infarction with excimer laser-The therapeutic use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.Efficacy and safety of argatroban in patients with heparin induced thrombocytopenia undergoing endovascular intervention for peripheral arterial disease.Rheolytic thrombectomy in patients with massive and submassive acute pulmonary embolism.Occurrence, predictors, and outcomes of post-percutaneous coronary intervention thrombocytopenia in an unselected population.The safety of clopidogrel.Safety of clopidogrel in older patients: a nonrandomized, parallel-group, controlled, two-centre study.Impact of a Pharmacist-Directed Anticoagulation Service on the Quality and Safety of Heparin-Induced Thrombocytopenia Management.Glycoprotein IIb/IIIa inhibitor associated severe thrombocytopenia in patients with coronary artery disease: Clinical course and outcomes.New and emerging anticoagulant therapy for atrial fibrillation and acute coronary syndrome.Impact of an immunoglobulin G-specific enzyme-linked immunosorbent assay on the management of heparin-induced thrombocytopenia.Treatment of heparin-induced thrombocytopenia before and after the implementation of a hemostatic and antithrombotic stewardship program.Intra-aortic balloon pumping and thrombocytopenia in patients with acute coronary syndrome : Incidence, risk factors, and prognosis.Hirudin (desirudin) and Hirulog (bivalirudin) in acute ischaemic syndromes and the rationale for the Hirulog/Early Reperfusion Occlusion (HERO-2) Study.The Thrombolysis in Myocardial Infarction (TIMI) trials: the first decade.The effects of a low international normalized ratio on thromboembolic and bleeding complications in patients with mechanical mitral valve replacement.Reduction in ST segment elevation after thrombolysis predicts either coronary reperfusion or preservation of left ventricular function.Thrombolytic treatment in acute myocardial infarction: neutrophil activation, peripheral leucocyte responses, and myocardial injury.A pilot study of the efficacy and safety of bolus administration of alteplase in acute myocardial infarction.
P2860
Q24792815-DF15900C-E421-432F-9000-8CCAE6509AF2Q24792897-EDBD2A8C-4B20-4B56-9A84-CE002FF0EBA3Q26778578-F3A740B2-1036-44EA-B9B7-5F7ADA76176BQ27008920-5D66C4CC-C801-4702-A7F4-1DBB0B261F83Q27026079-32DC2181-5529-4610-A115-5BC5524AB0B5Q27026934-ABAB5AA9-DD13-4188-8CA0-B0C41E1D4336Q28219423-A76A0283-E1F5-4ED7-8BFC-3B10D4833E72Q28360267-6957BDCD-5F77-4941-A4BF-959FD106B3D9Q30239889-32CE6D7A-F193-4E72-BAB8-375E4A485A72Q30248368-BD70D542-3590-46CD-8E81-CFCE96B61B4CQ30352952-34B70D74-764F-4991-8770-24F38C07E34BQ30410761-ADE0C4FD-571E-4577-9C0E-62E3C10E7C7BQ30411154-8E944A17-5E7D-403D-A30E-3CF2C4202ED1Q30486060-375C4BDC-B692-438C-BC66-9B0730C5BDCCQ30501045-DFDB61B8-9A9C-4A89-82FE-124A6497EB9CQ30542491-51BA4F2B-83C3-458F-B109-607D742F7798Q30652275-649274AC-2ECC-46CF-B83A-2500BBFD0C2EQ30664538-A4AB4E7B-D554-4006-935E-EF5134AF9048Q30665648-4C355AE2-B256-4511-AE1B-8B077ECC56AEQ30815367-D3841CF3-767D-4D8D-BB16-DE829F5AF76EQ31003629-99CE6A75-5B97-4D4B-BB1F-E03DB2583547Q31137372-49E6AFE1-48AC-4483-BBA3-BFF016903125Q33367036-E8D342B4-C0D9-430E-A7F4-94219E29A59FQ33379961-B4948997-8BED-4ADE-A76E-D113B5EB2F43Q33383401-C1C7AAFE-C6B0-4F8C-91EF-0E4E41964F8CQ33383454-78A4DE6E-AFD3-4F7B-81C9-B1B5BF1FF7D2Q33392895-442EAFF9-4782-4A65-8468-87388ADFECB8Q33393888-4C9A8FA0-17FC-4635-AAFA-97E97879BE55Q33394050-3AD06889-9938-4439-BCB0-AD73B5230660Q33397185-E919B070-6152-4C3B-AA46-91F45AA020F5Q33397359-21E06402-0C68-4D7D-A0EE-A1A928620046Q33408778-034A3100-4A73-4169-834E-CD46AA2C1B05Q33434438-F5A22539-DEC1-4ADC-B356-2153704A359FQ33443820-B60CCB0F-A341-431A-95FA-8450B399BF14Q33503948-C15ACCEA-24A9-4BEA-91F2-AEA33400B421Q33568780-FC486B2F-A9DC-46B9-A9FA-D0E5506CF739Q33603765-50AF28C1-DA84-4EC8-A991-3F04C34E2EC7Q33610405-1C64F44F-A039-4553-98D9-5E0807F8E786Q33611066-558BA5AD-EDCD-4EC8-8A16-A03597F47440Q33611181-247A0015-CD91-4ADB-9DF3-C7E0335DDDB8
P2860
Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Thrombolysis in Myocardial Inf ...... gs through hospital discharge.
@en
Thrombolysis in Myocardial Inf ...... gs through hospital discharge.
@nl
type
label
Thrombolysis in Myocardial Inf ...... gs through hospital discharge.
@en
Thrombolysis in Myocardial Inf ...... gs through hospital discharge.
@nl
prefLabel
Thrombolysis in Myocardial Inf ...... gs through hospital discharge.
@en
Thrombolysis in Myocardial Inf ...... gs through hospital discharge.
@nl
P2093
P921
P356
P1433
P1476
Thrombolysis in Myocardial Inf ...... gs through hospital discharge.
@en
P2093
Chesebro JH
Francis CK
Knatterud G
Ludbrook P
P304
P356
10.1161/01.CIR.76.1.142
P407
P577
1987-07-01T00:00:00Z